BRIEF-Valeant Pharmaceuticals receives lender consent for credit facility amendment

Thu Aug 18, 2016 8:14am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

Aug 18 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant Pharmaceuticals receives lender consent for credit facility amendment

* Amendment will reduce interest coverage maintenance covenant to 2.0x, providing additional headroom

* Amendment will permit issuance of secured notes with shorter maturities to repay term loans

* Amendment provides additional flexibility to sell assets

* Amendment will permit incurrence of other debt to repay term loans

* Amendment will provide additional flexibility to sell assets

* Valeant Pharmaceuticals International Inc says amendment provides with additional flexibility

* Also agreed to increase each of applicable interest rate margins on its credit facility by 0.50%   Continued...